Tirzepatide, a recently approved medication, is generating considerable interest within the scientific community. It functions differently from common diabetes therapies , targeting two receptors involved in blood regulation and satiety. Initial research have demonstrated impressive efficacy in reducing blood glucose in individuals with diabetes of